Our Stories
Latest News
Innovation
Caring & Giving
Personal Stories
Health & Wellness
Our Heritage
Our Company
About J&J
Our Credo
Our Leadership Team
Diversity & Inclusion
Empowering Women
Our Heroes
Innovation at J&J
Office of the Chief Medical Officer
J&J Health and Wellness Solutions
Policies & Statements
Code of Business Conduct
Corporate Reports
Products
Consumer Products
Medical Devices
Pharmaceutical Products
Procurement
Value Pillars
Supplier Diversity
Supplier Standards
Careers
What We Do
How We Hire
Job Spotlight
Employee Benefits
Students
Innovation
Career Stories
Media Center
Investors
Corporate Governance
Quarterly Results
SEC Filings
News Releases
Pharmaceutical Pipeline
2018 Janssen Transparency Report
2017 Health for Humanity Report
Stock Information
Webcasts & Presentations
Investor Fact Sheet
Our Societal Impact
Global Community Impact
Global Public Health
Global Environmental Health
Citizenship & Sustainability Reporting
Follow Us
Facebook
Instagram
LinkedIn
Twitter
YouTube
Explore more Johnson & Johnson sites:
Australia
Argentina
Brazil
Canada
Chile
China
Colombia
Costa Rica
Czech Republic
Ecuador
Germany
India
Japan
Mexico
New Zealand / Pacific
Paraguay
Peru
Philippines
Russia
Switzerland
German
English
French
Italian
United States
Uruguay
Venezuela
Share
Latest News
What You Need to Know About Johnson & Johnson's 2019 First-Quarter Earnings
What You Need to Know About Johnson & Johnson's 2019 First-Quarter Earnings
New Study Shows Researchers May Be One Step Closer to Intercepting Lung Cancer Earlier
How Johnson & Johnson Is Helping Tackle a Devastating Tropical Disease That Impacts Kids
5 Things to Know About the 2018 Janssen U.S. Transparency Report
Featured Stories
April 03, 2019
Johnson & Johnson Named a LinkedIn Top Company for 2019
Johnson & Johnson Named a LinkedIn Top Company for 2019
January 22, 2019
Johnson & Johnson Named a 2019
Fortune
World’s Most Admired Company
Johnson & Johnson Named a 2019
Fortune
World’s Most Admired Company
November 20, 2018
Putting Kids Around the Globe First: Johnson & Johnson Announces a $10 Million Pledge to UNICEF
Putting Kids Around the Globe First: Johnson & Johnson Announces a $10 Million Pledge to UNICEF
November 20, 2018
Johnson & Johnson Earns a Top Spot on the 2018 Access to Medicine Index
Johnson & Johnson Earns a Top Spot on the 2018 Access to Medicine Index
November 16, 2018
Acuvue Oasys
®
With Transitions™ Light Intelligent Technology™ Contact Lenses Named One of
Time
's Best Inventions of 2018
Acuvue Contact Lenses Named One of
Time
's Best Inventions of 2018
November 11, 2018
Helping Kids See Clearly: Johnson & Johnson Vision Teams Up With the Singapore Eye Research Institute to Launch a New Myopia Initiative
Johnson & Johnson Vision Teams Up With the Singapore Eye Research Institute to Launch a New Myopia Initiative
See All Stories
Johnson's® Baby Unveils a Groundbreaking 100% Ingredient Transparency Disclosure For Its Products
Read the Story
Johnson & Johnson and Boston University Announce a New Alliance Focused on Tackling Lung Cancer
Read the Story
Video: A Message From Johnson & Johnson CEO Alex Gorsky About Talc Safety
Read the Story
More from Johnson & Johnson
Innovation
“My Life's Mission Is Finding a Way to Prevent HIV”: Meet the Lead Scientist on a Promising Female-Focused Vaccine Trial
“My Life's Mission Is Finding a Way to Prevent HIV”: Meet the Lead Scientist on a Promising Female-Focused Vaccine Trial
Latest News
New Study Shows Researchers May Be One Step Closer to Intercepting Lung Cancer Earlier
New Study Shows Researchers May Be One Step Closer to Intercepting Lung Cancer Earlier
Latest News
What You Need to Know About Johnson & Johnson's 2019 First-Quarter Earnings
What You Need to Know About Johnson & Johnson's 2019 First-Quarter Earnings
This site uses cookies as described in our
Cookie Policy
. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
Accept
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue
